Point: patients with native aortic regurgitation can be treated with transcatheter aortic valve implantation
- 16 April 2021
- Vol. 107 (24), 1938-1941
- https://doi.org/10.1136/heartjnl-2021-319179
Abstract
Approximately 2% of people between the ages of 70 and 83 suffer from moderate or greater aortic regurgitation (AR) in the United States. Left untreated, this disease is progressive and fatal; however, up to 8% of patients with AR, who meet the criteria for surgical intervention, do not receive treatment. As such, there is a pressing need to address the lack of treatment options for the thousands of patients with AR who meet a class I indication for aortic valve replacement but who still do not receive surgery. The advent of transcatheter aortic valve implantation (TAVI) has significantly altered the paradigm of treatment for valvular heart disease and is now a well-established therapeutic option for patients with severe aortic stenosis. While transcatheter devices dedicated for the treatment of AR are under investigation, they are not commercially available at this time. Nevertheless, there is a growing body of data that demonstrate acceptable safety and efficacy for the off-label use of current TAVI devices for the treatment of severe AR. Given the dearth of treatment options for inoperable patients with severe AR, available TAVI devices should be considered for this patient population.Keywords
This publication has 24 references indexed in Scilit:
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsThe New England Journal of Medicine, 2016
- Initial German Experience With Transapical Implantation of a Second-Generation Transcatheter Heart Valve for the Treatment of Aortic RegurgitationJACC: Cardiovascular Interventions, 2014
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive SummaryJournal of Invasive Cardiology, 2014
- Transcatheter Aortic Valve Implantation for Pure Severe Native Aortic Valve RegurgitationJournal of Invasive Cardiology, 2013
- Guidelines on the management of valvular heart disease (version 2012)European Journal of Cardio-Thoracic Surgery, 2012
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsThe New England Journal of Medicine, 2011
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryThe New England Journal of Medicine, 2010
- A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart DiseaseEuropean Heart Journal, 2003
- Mortality and Morbidity of Aortic Regurgitation in Clinical PracticeJournal of the American College of Cardiology, 1999
- Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)The American Journal of Cardiology, 1999